Page 5 - வாடிம் அலெக்ஸாண்ட்ரே கொள்ளை ரீஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வாடிம் அலெக்ஸாண்ட்ரே கொள்ளை ரீஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வாடிம் அலெக்ஸாண்ட்ரே கொள்ளை ரீஸ் Today - Breaking & Trending Today

Investegate |Novacyt S.A. Announcements | Novacyt S.A.: Total Voting Rights


Total Voting Rights
 
Paris, France and Camberley, UK - 1 April 2021 -
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the Liquidity Agreement ). The Liquidity Agreement is governed by French law and is further summarised in the notes for editors section below.
 
During the period from 1 March to 31 March 2021, Invest Securities purchased 2,897 ordinary shares at a maximum price of €8.90 and a minimum price of €7.70 and sold 3,152 ordinary shares at a maximum price of €8.93 and a minimum price of €7.93 under the Liquidity Agreement. The total number of ordinary shares in the Company, which are held in treasury as at close of business on 31 March 2021, is 5,017. ....

France General , United Kingdom , Graham Mullis , Vadim Alexandre Rob Rees , Matthew Johnson Charlie Bouverat , James Mccarthy , Freddie Barnfield James , Durgetto Yannick Petit , Numis Securities Limited Joint Broker , Financial Conduct Authority Under Part , Sp Angel Corporate Finance , Novacyt Group , Consulting International , Company Articles , Agreement Monthly Update , Invest Securities , Liquidity Agreement , French Commercial Code , Financial Conduct Authority , Chief Executive , Chief Financial , Nominated Adviser , Charlie Bouverat , Corporate Finance , Rob Rees , Corporate Broking ,

Investegate |Novacyt S.A. Announcements | Novacyt S.A.: Launch of mobile processing laboratories


 
to detect COVID-19
 
Paris, France and Camberley, UK - 17 March 2021 -
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the expansion of its VersaLab™ service with the launch of mobile processing laboratories (MPL) to provide rapid turnaround polymerase chain reaction (PCR) testing on-site. Testing will be performed using mid-nose nasal swabs, which were found to be effective and well tolerated compared to the more invasive nasopharyngeal swabs in the interim review of Queen Mary University of London s clinical trial in care homes, as announced by the Company on 16 November 2020.
 
VersaLab™ was launched in December 2020 to support private sector testing of infectious diseases, initially focused on COVID-19. This has enabled Novacyt to identify a growing number of UK and international mobile testing opportunities across the private sector. ....

France General , United Kingdom , Graham Mullis , Vadim Alexandre Rob Rees , Matthew Johnson Charlie Bouverat , James Mccarthy , Freddie Barnfield James , Durgetto Yannick Petit , Novacyt Mpls , Numis Securities Limited Joint Broker , Sp Angel Corporate Finance , Novacyt Group , Queen Mary University Of London , Department Of Health , Consulting International , Care Technology Validation Group , Queen Mary University , Social Care , Technology Validation , Chief Executive Officer , Chief Executive , Chief Financial , Nominated Adviser , Charlie Bouverat , Corporate Finance , Rob Rees ,

Investegate |Novacyt S.A. Announcements | Novacyt S.A.: Correction: Research and Development Update


 
 
This is a correction to the Research and Development Update announcement published at 7:00am on 24 February 2021 (RNS number 1141Q) which has been amended with the following underlined additions to make it consistent with the French announcement released on Euronext at 8:00am CET on 24 February 2021.
 
Under the subtitle Launch of CE Mark COVID-HT Direct
·
Novacyt announces the launch of its next generation high-throughput PCR test for COVID-19 (COVID-HT Direct), which has been CE Mark approved using independent validated data.
·
The new COVID-HT Direct uses pharyngeal swabs collected in viral transport media (without guanidine) and saline
 
Under the subtitle Successful completion and publication of TVG validation of PROmate™ ....

United Kingdom , City Of , United States , France General , Graham Mullis , Vadim Alexandre Rob Rees , Matthew Johnson Charlie Bouverat , James Mccarthy , Freddie Barnfield James , Numis Securities Limited Joint Broker , Consulting International , Regulatory Agency , Sp Angel Corporate Finance , Novacyt Group , Technology Validation Group , Queen Mary University Of London , Technical Validation Group , Development Update , Queen Mary University , Latin America , Validation Group , Chief Executive , Chief Financial , Nominated Adviser , Charlie Bouverat , Corporate Finance ,